$123.93-0.51 (-0.41%)
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally.
Teleflex Incorporated in the Healthcare sector is trading at $123.93 with a market capitalization of $5.4B. Wall Street consensus targets $154.73 (11 analysts), implying a +24.9% move over the next 12 months. The stock is currently 15% below its 52-week high of $145.00, remaining 0.3% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality. The Whystock Score of 75/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $570.33Mβ | $548.26Mβ | -$401.87Mβ | $913.02Mβ | $442.52M |
| Gross Profit | $331.71Mβ | $307.43Mβ | -$151.41Mβ | $451.64Mβ | $265.83M |
| Operating Income | $73.07Mβ | $37.03Mβ | -$164.65Mβ | $112.65Mβ | $101.84M |
| Net Income | $99.69Mβ | -$8.15Mβ | -$714.33Mβ | -$408.89Mβ | $122.58M |
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia...